LDB
ZBH icon

Lee, Danner & Bass’s Zimmer Biomet ZBH Stock Holding History

Lee, Danner & Bass’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,336
Closed -$210K – 253
2025
Q4 		$210K Sell
2,336
-125
-5% -$11.9K 0.02% 228
2025
Q3 		$242K Hold
2,461
– – 0.02% 216
2025
Q2 		$224K Sell
2,461
-170
-6% -$16.4K 0.02% 213
2025
Q1 		$298K Hold
2,631
– – 0.02% 196
2024
Q4 		$278K Hold
2,631
– – 0.02% 205
2024
Q3 		$284K Hold
2,631
– – 0.02% 197
2024
Q2 		$286K Buy
+2,631
New +$310K 0.02% 192
2023
Q4 		$320K Sell
2,631
-120
-4% -$13.4K 0.03% 182
2023
Q3 		$309K Hold
2,751
– – 0.03% 180
2023
Q2 		$401K Sell
2,751
-1,030
-27% -$140K 0.03% 167
2023
Q1 		$489K Hold
3,781
– – 0.05% 155
2022
Q4 		$482K Hold
3,781
– – 0.05% 155
2022
Q3 		$395K Hold
3,781
– – 0.04% 157
2022
Q2 		$397K Sell
3,781
-405
-10% -$48K 0.04% 158
2022
Q1 		$535K Sell
4,186
-167
-4% -$20.1K 0.05% 150
2021
Q4 		$537K Hold
4,353
– – 0.05% 149
2021
Q3 		$619K Hold
4,353
– – 0.06% 144
2021
Q2 		$680K Hold
4,353
– – 0.06% 140
2021
Q1 		$676K Hold
4,353
– – 0.07% 135
2020
Q4 		$651K Sell
4,353
-324
-7% -$45.8K 0.07% 130
2020
Q3 		$618K Sell
4,677
-83
-2% -$10.8K 0.07% 127
2020
Q2 		$552K Sell
4,760
-56
-1% -$6.45K 0.07% 130
2020
Q1 		$473K Sell
4,816
-21
-0.4% -$2.75K 0.07% 131
2019
Q4 		$703K Hold
4,837
– – 0.07% 130
2019
Q3 		$645K Hold
4,837
– – 0.07% 134
2019
Q2 		$553K Sell
4,837
-360
-7% -$42.2K 0.06% 141
2019
Q1 		$644K Sell
5,197
-14,505
-74% -$1.65M 0.07% 133
2018
Q4 		$1.98M Buy
19,702
+883
+5% +$99.3K 0.23% 84
2018
Q3 		$2.4M Sell
18,819
-464
-2% -$55.2K 0.24% 81
2018
Q2 		$2.09M Buy
19,283
+5,583
+41% +$608K 0.22% 85
2018
Q1 		$1.45M Buy
13,700
+211
+2% +$24.5K 0.15% 100
2017
Q4 		$1.58M Buy
13,489
+307
+2% +$34.7K 0.16% 99
2017
Q3 		$1.5M Buy
13,182
+1,854
+16% +$214K 0.16% 98
2017
Q2 		$1.41M Buy
11,328
+172
+2% +$20.4K 0.16% 98
2017
Q1 		$1.32M Sell
11,156
-77
-0.7% -$8.73K 0.15% 99
2016
Q4 		$1.13M Buy
11,233
+4,789
+74% +$513K 0.13% 102
2016
Q3 		$813K Hold
6,444
– – 0.1% 109
2016
Q2 		$753K Buy
6,444
+250
+4% +$28.3K 0.09% 113
2016
Q1 		$693K Sell
6,194
-167
-3% -$16.2K 0.09% 112
2015
Q4 		$634K Hold
6,361
– – 0.08% 113
2015
Q3 		$580K Buy
6,361
+669
+12% +$67.1K 0.08% 118
2015
Q2 		$604K Hold
5,692
– – 0.07% 118
2015
Q1 		$649K Sell
5,692
-103
-2% -$11.8K 0.08% 112
2014
Q4 		$638K Buy
5,795
+52
+0.9% +$5.48K 0.08% 110
2014
Q3 		$561K Buy
5,743
+1,865
+48% +$183K 0.07% 114
2014
Q2 		$391K Buy
+3,878
New +$378K 0.05% 126

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lee, Danner & Bass's ZBH Position: Q1 2026 in Review

Lee, Danner & Bass sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,336 shares — an estimated $210K sold.

Lee, Danner & Bass first reported a position in ZBH in Q2 2014 and held it in 46 quarters. The position peaked at $2.4M in Q3 2018. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Lee, Danner & Bass reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Lee, Danner & Bass sold 2,336 Zimmer Biomet shares in Q1 2026, an estimated $210K.
  • Lee, Danner & Bass first reported a position in Zimmer Biomet in Q2 2014 and held it in 46 quarters.
  • Lee, Danner & Bass's Zimmer Biomet position peaked at $2.4M in Q3 2018.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Lee, Danner & Bass's 13F filing for Q1 2026, filed 28 Apr 2026.